文献速递白血病淋巴瘤

功能蛋白质组学定义白血病细胞中Bcr-Abl p210和p190激酶的差异信号网络

Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.
PubMed 文献 · Leukemia · 2017-01-23

研究对白血病相关的Bcr-Abl两种主要亚型p210和p190进行定量比较蛋白质组学分析,发现相互作用组和酪氨酸磷酸化蛋白质组存在强烈差异并经验证,p210更强烈激活Stat5和Erk1/2,而p190激活Lyn激酶,为理解Bcr-Abl信号、白血病转化机制及激酶抑制剂反应提供依据。

要点

  • p210与p190在相互作用组和酪氨酸磷酸化蛋白质组上存在强烈差异并经实验验证。
  • 调控网格蛋白介导内吞的AP2衔接蛋白复合物优先与p190结合,磷酸酶Sts1在p210中富集。
  • p210对Stat5转录因子和Erk1/2激酶的激活更强,而Lyn激酶由p190激活。

核心结论

  • p210与p190激酶在蛋白质相互作用和信号通路激活上存在强烈差异,这些差异与二者驱动的不同疾病及激酶抑制剂反应相关。

研究设计与样本

  • 对Bcr-Abl p210和p190进行定量比较蛋白质组学研究,并验证所发现的差异。

主要发现

  • p210和p190在相互作用组和酪氨酸磷酸化蛋白质组上存在强烈差异并经实验验证。
  • 调控网格蛋白介导内吞的AP2衔接蛋白复合物优先与p190结合,磷酸酶Sts1在p210中富集。
  • p210对Stat5转录因子和Erk1/2激酶的激活更强,而Lyn激酶由p190激活。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The two major isoforms of the oncogenic Bcr-Abl tyrosine kinase, p210 and p190, are expressed upon the Philadelphia chromosome translocation. p210 is the hallmark of chronic myelogenous leukemia, whereas p190 occurs in the majority of B-cell acute lymphoblastic leukemia. Differences in protein interactions and activated signaling pathways that may be associated with the different diseases driven by p210 and p190 are unknown. We have performed a quantitative comparative proteomics study of p210 and p190. Strong differences in the interactome and tyrosine phosphoproteome were found and validated. Whereas the AP2 adaptor complex that regulates clathrin-mediated endocytosis interacts preferentially with p190, the phosphatase Sts1 is enriched with p210. Stronger activation of the Stat5 transcription factor and the Erk1/2 kinases is observed with p210, whereas Lyn kinase is activated by p190. Our findings provide a more coherent understanding of Bcr-Abl signaling, mechanisms of leukemic transformation, resulting disease pathobiology and responses to kinase inhibitors.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Reckel S, Hamelin R, Georgeon S, et al. Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics. Leukemia. 2017. PMID: 28111465. doi:10.1038/leu.2017.36

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。